Cocrystal Pharma, Inc. announced the unfortunate passing of Dr. Anthony Japour, a member of its board of directors, on March 10, 2026. This news may have a noticeable negative impact on the company, as it reflects a loss in leadership and expertise at a critical time for the firm. The company has not indicated any immediate succession plans or changes in governance following this event.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.